Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Announces Initiation of Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne 2023-12-05 16:50
J INTS BIO Gives Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, at ESMO Asia 2023 2023-12-05 15:16
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development 2023-12-05 15:00
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD) 2023-12-05 06:00
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia 2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis 2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck 2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS 2023-12-04 21:00
Latest Updates of Viva's Portfolio Companies 2023-12-04 17:55
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer 2023-12-04 14:51
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent 2023-12-04 13:00
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China 2023-12-04 08:58
The Shanghai Cooperation Organization Traditional Medicine Forum opened 2023-12-01 17:49
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer 2023-12-01 14:41
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023 2023-12-01 12:00
CNN's 'Vital Signs' explores the prospects of phage therapy to treat drug-resistant superbugs 2023-12-01 11:29
Everest Medicines Announces Positive Topline Results from Induction Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderate-to-Severe Active Ulcerative Colitis 2023-12-01 07:33
Bushu Pharma Recognized with Frost & Sullivan's 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing and Robust Supply Chain Solutions 2023-11-30 22:30
Registrational Phase III CLARIFY trial in prostate cancer commences 2023-11-30 22:16
1 63 64 65 66 67 413